Functional knockout of the glucose transporter 2 in mice overexpressing a dominant negative mutation
Functional knockout of the glucose transporter 2 in mice overexpressing a dominant negative mutation
批准号:
14570716
负责人:
OHURA Toshihiro
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fanconi-Bickel syndrome (FBS) is an autosomal recessive disorder characterized by hepatorenal glycogen accumulation, Fanconi nephropathy and impaired utilization of glucose and galactose. Recently several mutations in GLUT2 gene were reported in FBS patients. We performed molecular analysis of three Japanese patients and found four novel mutations : a splice-site mutation (IVS2-2A>G), a nonsense mutation (Q287X) and two missense mutations (L389P and V423E). The family members who presented renal glucosuria were heterozygous for V423E mutation. If some mutant GLUT2 proteins such as V423E have a dominant-negative effect, an oligomer composed of mutant and wild-type proteins could result in abolition of transport activity.In this experiment, we tried to create model mouse for Fanconi-Bickel syndrome using functional knockout by overexpression of dominant negative inhibitor. The expression vector consists of the CAG promoter, a loxP, the DsRed, a second loxP, the mutant GLUT2 cDNA (V423E), the IRES, and the EGFP, in that order. The CDRE-GLUT2 unit was excised and microinjected into fertilized mouse eggs. We finally obtained 4 different strains, which over expressed mutant GLUT2 cDNA. We measured the blood glucose levels of these mice and checked the glucosuria but there were no significant difference between control mice and transgenic mice. We speculated that expression of mutant GLUT2 in transgenic mice was not enough to produce functional knockout or that V423E mutation had not dominant-negative effects.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
坂本修, 小川英伸, 大浦敏博他: "Fanconi-Bickel症候群の3例"特殊ミルク情報. 第37号. 16-20 (2002)
Osamu Sakamoto、Hienobu Okawa、Toshihiro Oura 等:“Fanconi-Bickel 综合征的三例”特殊牛奶信息第 37. 16-20 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Strategy for prevention of development of CTLN2 in patients with citrin deficiency
-
批准号:18591138
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.71万
-
财政年份:2006
-
负责人:OHURA Toshihiro
-
依托单位:
Mutation analysis of the GLUT2 gene in patients with Fanconi-Bickel syndrome
-
批准号:12670722
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:OHURA Toshihiro
-
依托单位:
Propionic Acidemia : Mutation Analysis of the alpha-subunit of Propionyl-CoA Carboxylase.
-
批准号:09670781
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:1997
-
负责人:OHURA Toshihiro
-
依托单位:
Propionic acidemia : bacterial expression system for propionyl CoA carboxylase.
-
批准号:06670762
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1994
-
负责人:OHURA Toshihiro
-
依托单位:
Propionic acidemia : Molecular analysis of beta subnit deficient Japanese petients
-
批准号:04670575
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1992
-
负责人:OHURA Toshihiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
MOF组蛋白乙酰转移酶在NAFLD中的作用机制研究:基于PPARγ/GLUT2信号通路调节的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
基于结直肠癌肝转移类器官模型探索HNF4A/GLUT2轴诱导有氧糖酵解重编程影响肿瘤干性介导结直肠癌肝转移的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:莫少波
-
依托单位:
HNF4α-GLUT2通路在达格列净促进胰腺前体细胞向胰岛β细胞分化中的作用及机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:杨琨
-
依托单位:
GLUT2介导肠道T1R2/T1R3调控奶山羊小肠葡萄糖吸收的分子机制
-
批准号:32102569
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:雷新建
-
依托单位:
果糖偶联壳聚糖两亲性递送体系的构建及其诱导GLUT2调控的胞吞作用机制研究
-
批准号:32101941
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:杜志阳
-
依托单位:
小檗碱通过IGF-1R—PLC-beta2—GLUT2信号通路抑制糖尿病小鼠小肠上皮GLUT2转位的机制研究
-
批准号:31971059
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:董玲
-
依托单位:
基于肠/胰甜味受体介导的GLP-1/胰岛素分泌和GLUT2表达探讨半夏泻心汤调控糖稳态失衡的分子机制
-
批准号:81973740
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:江国荣
-
依托单位:
阿魏酰麦芽糊精与花色苷-sGLT1/GLUT2的互作机制及其对花色苷跨膜转运的影响
-
批准号:31801458
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2018
-
负责人:马懿
-
依托单位:
T1R2/3-PKC βⅡ-Ca2+通路调控小肠葡萄糖运载蛋白GLUT2及益气健脾方药的干预作用
-
批准号:81072753
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:郭文峰
-
依托单位: